Literature DB >> 28657421

Chemo brain: From discerning mechanisms to lifting the brain fog-An aging connection.

Anna Kovalchuk1, Bryan Kolb1.   

Abstract

Mounting evidence indicates that cancer treatments cause numerous deleterious effects, including central nervous system (CNS) toxicity. Chemotherapy-caused CNS side effects encompass changes in cognitive function, memory, and attention, to name a few. Although chemotherapy treatment-induced side effects occur in 16-75% of all patients, the mechanisms of these effects are not well understood. We have recently proposed a new epigenetic theory of chemo brain and, in a pioneer study, determined that cytotoxic chemotherapy agents induce oxidative DNA damage and affect molecular and epigenetic processes in the brain, and may be associated with brain aging processes. In this paper, we discuss the implications of chemo brain epigenetic effects and future perspectives, as well as outline potential links with brain aging and future translational research opportunities.

Entities:  

Keywords:  epigenetics; hippocampus; prefrontal cortex; sex differences in brain

Mesh:

Substances:

Year:  2017        PMID: 28657421      PMCID: PMC5539816          DOI: 10.1080/15384101.2017.1334022

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  61 in total

Review 1.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.

Authors:  Rudolf Jaenisch; Adrian Bird
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

Review 2.  Transcribed dark matter: meaning or myth?

Authors:  Chris P Ponting; T Grant Belgard
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

Review 3.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

Review 4.  Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis.

Authors:  Igor Koturbash; Franz J Zemp; Igor Pogribny; Olga Kovalchuk
Journal:  Mutat Res       Date:  2010-05-21       Impact factor: 2.433

Review 5.  The epigenetics of aging and neurodegeneration.

Authors:  Roy Lardenoije; Artemis Iatrou; Gunter Kenis; Konstantinos Kompotis; Harry W M Steinbusch; Diego Mastroeni; Paul Coleman; Cynthia A Lemere; Patrick R Hof; Daniel L A van den Hove; Bart P F Rutten
Journal:  Prog Neurobiol       Date:  2015-06-11       Impact factor: 11.685

Review 6.  Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.

Authors:  Hannah R Wardill; Kimberley A Mander; Ysabella Z A Van Sebille; Rachel J Gibson; Richard M Logan; Joanne M Bowen; Stephen T Sonis
Journal:  Int J Cancer       Date:  2016-07-15       Impact factor: 7.396

7.  Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release.

Authors:  Riejanne Seigers; Jessica Timmermans; Hans J van der Horn; Erik F J de Vries; Rudi A Dierckx; Lydia Visser; Sanne B Schagen; Frits S A M van Dam; Jaap M Koolhaas; Bauke Buwalda
Journal:  Behav Brain Res       Date:  2009-10-17       Impact factor: 3.332

8.  Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Linda Titus-Ernstoff; Karen Skalla; Marie Bakitas; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2005-07-01       Impact factor: 44.544

9.  Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications.

Authors:  Teresita L Briones; Julie Woods
Journal:  BMC Neurosci       Date:  2011-12-09       Impact factor: 3.288

Review 10.  Physiological and pathological implications of 5-hydroxymethylcytosine in diseases.

Authors:  Jing Liang; Fan Yang; Liang Zhao; Chongwei Bi; Benzhi Cai
Journal:  Oncotarget       Date:  2016-07-26
View more
  9 in total

1.  Inflammatory Bowel Disease Self-Management: Exploring Adolescent Use of an Online Instagram Support Community.

Authors:  Caeli Malloy; Susan M Rawl; Wendy R Miller
Journal:  Gastroenterol Nurs       Date:  2022-07-13       Impact factor: 1.159

2.  Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial.

Authors:  Molly E Ream; Emily A Walsh; Jamie M Jacobs; Chloe Taub; Marc Lippman; Natasha Schaefer-Solle; Steven A Safren; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2021-08-19       Impact factor: 4.624

3.  Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?

Authors:  Quirien Oort; Linda Dirven; Sietske A M Sikkes; Neil Aaronson; Florien Boele; Christine Brannan; Jonas Egeter; Robin Grant; Martin Klein; Irene M Lips; Yoshitaka Narita; Hitomi Sato; Monika Sztankay; Günther Stockhammer; Andrea Talacchi; Bernard M J Uitdehaag; Jaap C Reijneveld; Martin J B Taphoorn
Journal:  Neurooncol Pract       Date:  2022-02-26

4.  Brain Fog in Hypothyroidism: Understanding the Patient's Perspective.

Authors:  Matthew D Ettleson; Ava Raine; Alice Batistuzzo; Samuel P Batista; Elizabeth McAninch; Maria Cristina T V Teixeira; Jacqueline Jonklaas; Neda Laiteerapong; Miriam O Ribeiro; Antonio C Bianco
Journal:  Endocr Pract       Date:  2021-12-08       Impact factor: 3.701

5.  Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer.

Authors:  Afroz S Mohammad; Chris E Adkins; Neal Shah; Rawaa Aljammal; Jessica I G Griffith; Rachel M Tallman; Katherine L Jarrell; Paul R Lockman
Journal:  BMC Cancer       Date:  2018-12-07       Impact factor: 4.430

6.  Does a Cancer Diagnosis in Mid-to-Later Life Modify Racial Disparities in Memory Aging?

Authors:  Marisa R Eastman; Monica Ospina-Romero; Ashly C Westrick; Jasdeep S Kler; Medellena Maria Glymour; Ekland Abdiwahab; Lindsay C Kobayashi
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-02-04       Impact factor: 2.357

7.  Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments.

Authors:  Jason Thomas Duskey; Arianna Rinaldi; Ilaria Ottonelli; Riccardo Caraffi; Chiara Alessia De Benedictis; Ann Katrin Sauer; Giovanni Tosi; Maria Angela Vandelli; Barbara Ruozi; Andreas Martin Grabrucker
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525

8.  Disentangling the cognitive, physical, and mental health sequelae of COVID-19.

Authors:  Conor J Wild; Loretta Norton; David K Menon; David A Ripsman; Richard H Swartz; Adrian M Owen
Journal:  Cell Rep Med       Date:  2022-09-07

Review 9.  Medical Cannabis in Pediatric Oncology: Friend or Foe?

Authors:  Megan Malach; Igor Kovalchuk; Olga Kovalchuk
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.